The latest UK HCAI surveillance framework monitors six major pathogens under mandatory reporting requirements, reflecting the evolving epidemiology of hospital-acquired infections in English healthcare systems. The monitored organisms include both gram-positive bacteria (MRSA and MSSA) and gram-negative species (E. coli, Pseudomonas aeruginosa, and Klebsiella spp.), alongside the anaerobic pathogen Clostridioides difficile.
This comprehensive surveillance approach generates real-time epidemiological data essential for antimicrobial stewardship programmes and infection prevention initiatives. By tracking resistance patterns and infection rates across NHS trusts, the UKHSA enables targeted interventions and evidence-based policy adjustments. The Q1 2026 data demonstrate measurable increases in multiple pathogen categories, underscoring the urgent need for coordinated antimicrobial resistance management strategies. These surveillance metrics directly inform clinical decision-making and resource allocation across healthcare systems, supporting both individual patient care and broader public health objectives.
Read the full article on GMJ Newsroom.
Was this article helpful?
